Seattle Genetics reported $-84576000 in Pre-Tax Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Abbvie ABBV:US $ 6290M 282M
Acadia Pharmaceuticals ACAD:US $ -43.4M 23.03M
Agios Pharmaceuticals AGIO:US $ -82.79M 8.09M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Astellas Pharma 4503:JP Y 35830M 54733M
Bayer BAYN:GR € 1537M 1825M
Biogen BIIB:US $ 814.2M 255M
Bluebird Bio BLUE:US $ -231.42M 25.67M
Celldex Therapeutics CLDX:US $ -13.37M 3.16M
Clovis Oncology CLVS:US $ -66.45M 0.04M
Daiichi Sankyo 4568:JP Y 47062M 72506M
Eisai 4523:JP Y 55783M 61588M
Eli Lilly And LLY:US $ 1988.6M 80.6M
Esperion Therapeutics ESPR:US $ -43668000 47.27M
Exelixis EXEL:US $ 124.89M 126.9M
Genmab GEN:DC DK 422M 1002M
GlaxoSmithKline GSK:LN 1482M 225M
Immunogen IMGN:US $ -30.74M 3.31M
Insmed INSM:US $ -116699000 25.3M
Karyopharm Therapeutics KPTI:US $ -53448000 3.82M
Macrogenics MGNX:US $ -39.94M 11.34M
Moderna Inc MRNA:US 3.06B 1.8B
Nektar Therapeutics NKTR:US $ -125.16M 3.89M
Novartis NOVN:VX SF 4424M 620M
Regeneron Pharmaceuticals REGN:US $ 3898.3M 2658.7M
Sanofi SAN:FP € 2180M 376M
Sarepta Therapeutics SRPT:US $ -81.76M 85.63M
Spectrum Pharmaceuticals SPPI:US $ -49.92M 14.24M
Teva Pharmaceutical TEVA:IT 794M 650M
Xencor XNCR:US $ 52.25M 54.74M
YTE INCY:US $ 199.6M 31.06M